Shen Jin Cao

Lycopodium japonicum Thunb.

Also known as: Club moss herb(English) 伸筋草(Chinese)

Shên Chin Ts'ao

Updated October 5, 2026 · Not yet clinically reviewed

Safety at a glance

Note

3 recorded drug interactions

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
wind-damp dispelling
Temperature
Warm
Taste
Bitter,Pungent
Channels
Liver,Spleen,Kidney

Functions

Dispels Wind-Dampness; Relaxes the Sinews and Unblocks the Collaterals; Disperses Cold; Reduces Swelling and Alleviates Pain

Traditional uses

Shen Jin Cao (lycopodium herb, club moss) is a warm, bitter herb used in Chinese medicine primarily to expel Wind-Cold-Damp from the channels and muscles, relieve joint and muscle pain, and relax the sinews. It is used for bi syndrome with stiffness, numbness, and pain in the joints and limbs, and for menstrual irregularities from stagnation. Its sinew-relaxing properties make it particularly applicable for spasms, cramps, and restricted range of motion from Wind-Cold-Damp obstruction.

Formulas using this herb

5 of 5 formulas

Botanical

Lycopodium japonicum is a perennial evergreen clubmoss (lycophyte) of the family Lycopodiaceae, native to moist forested slopes, ravines, and open mountain meadows across East and Southeast Asia. It produces long, prostrate, branching main stems that creep along the substrate, rooting at intervals and giving rise to erect, repeatedly forked aerial shoots 15 to 40 cm tall, densely clothed in narrow, linear-lanceolate, spirally arranged microphylls less than 1 cm long. Reproduction is by spores borne in cylindrical, terminal strobili at the tips of slender, leafless peduncles; the spores are yellow, oily, and extremely fine. The entire aerial herb is collected throughout the growing season for medicinal use, dried, and cut into segments.

Family
Lycopodiaceae
Pharmaceutical name
Herba Lycopodii
Parts used
whole_plant
Plant type
fern

Constituents

Lycopodine

Lycopodium alkaloid (lycopodine-type quinolizidine) · Principal lycopodine-type alkaloid of the whole herb; the species yields 83 characterised alkaloids in total, of which 48 are lycopodine-type

Inhibits lipopolysaccharide-induced release of pro-inflammatory mediators in BV2 microglial cells in vitro, one of ten L. japonicum alkaloids active in that assay across a range of IC50 4.23 to 64.97 micromolar (curcumin control IC50 3.12 micromolar). This is a cell-culture finding only; no human pharmacokinetic data exist for the compound taken as part of a decoction.

Lycojapodine A

Lycopodium alkaloid (fawcettimine-related, 6/6/6/7 tetracyclic with a six-membered lactone) · Trace alkaloid isolated from the whole herb

The most potent acetylcholinesterase inhibitor so far reported from this species, with an in vitro IC50 of 90.3 micromolar; it also showed anti-HIV-1 activity with an EC50 of 85 micrograms per millilitre by MTT assay. A micromolar IC50 is weak enzyme inhibition and is not comparable to huperzine A, which acts in the nanomolar range.

Lycojaponicumins A, B and C

Lycopodium alkaloids with an unprecedented 5/5/5/5/6 pentacyclic (A and B) or 6/5/5/6 tetracyclic (C) skeleton · Trace constituents; isolated in milligram quantities from bulk whole-herb extract

Suppress lipopolysaccharide-induced nitric oxide and pro-inflammatory cytokine production in BV2 microglia in vitro. Lycojaponicumins A and B were the first natural products described with a 1-aza-7-oxabicyclo[2.2.1]heptane moiety, so they are chemically novel rather than pharmacologically established.

alpha-Onocerin

Onocerane-type triterpenoid · Reported as a major triterpenoid of the whole herb

Inhibited acetylcholinesterase by 39.0 percent at 0.6 mg/mL in vitro, against galanthamine at 63.6 percent as the positive control. Lycoclavanol from the same plant gave 20.0 percent under the same conditions. These are weak, high-concentration effects.

Serratene-type triterpenoids (3-epilycoclavanol, lycernuic acid A, lycojaponicuminols A to F, lycopodiin A)

Serratane (serratene) triterpenoids · Together with the alkaloids these are the dominant constituent class; 27 serratane triterpenoids have been reported from the species

Moderately cytotoxic in vitro against A549 lung, HepG2 hepatocellular and MCF-7 breast carcinoma lines, with IC50 values of 2.28 to 11.81 micrograms per millilitre for the most active members. There is no in vivo or clinical antitumour evidence for this herb.

Huperzine E, 12-deoxyhuperzine O, 8-beta-hydroxyhuperzine E and huperzinine

Lycodine-type Lycopodium alkaloids · Trace alkaloids of the whole herb

These are huperzine-series congeners and are not huperzine A. Huperzine A itself is not among the 132 compounds reported from Lycopodium japonicum in the published phytochemical literature; it is a constituent of Huperzia serrata, a different clubmoss. The pharmacology of huperzine A should not be transferred to this drug.

Tricin

Flavone · Minor phenolic constituent

Showed moderate cytotoxicity against human K562 leukaemia cells in vitro with an IC50 of 11.68 micrograms per millilitre. Tricin is a widely distributed cereal and grass flavone and is not specific to this herb.

Drug interactions

Donepezil, rivastigmine, galantamine and other cholinesterase inhibitors

Theoretical · Low at customary decoction doses on current evidence · Evidence level: Theoretical

Lycopodium japonicum contains constituents with measurable acetylcholinesterase inhibition, but all of them are weak: lycojapodine A at IC50 90.3 micromolar, alpha-onocerin at 39 percent inhibition at 0.6 mg/mL and lycoclavanol at 20 percent at the same concentration. No whole-extract inhibition constant, oral bioavailability figure or human pharmacokinetic study exists for the drug. Additive cholinergic effect is therefore plausible in principle but is unsupported by any in vivo or clinical observation, and the concentrations required are far above anything a decoction is likely to deliver.

Clinical note: No dose change is indicated on present evidence. If a patient on a cholinesterase inhibitor develops nausea, bradycardia, sweating or cramping after starting this herb, stop the herb and reconsider the product identity, since a huperzine-containing clubmoss may have been supplied instead.

Huperzine A supplements labelled Chinese club moss (Huperzia serrata, Qian Ceng Ta)

Moderate · Moderate; matters because of misidentification rather than any property of Shen Jin Cao itself · Evidence level: Possible

Huperzia serrata and Lycopodium japonicum are both clubmosses and both trade in English under the loose name club moss, but only Huperzia serrata yields huperzine A, a potent reversible and selective acetylcholinesterase inhibitor marketed in China as an anti-Alzheimer drug and in the United States as a dietary supplement. Huperzine A carries genuine cholinergic interaction potential with cholinesterase inhibitors, cholinergic and anticholinergic agents, and beta-blockers through additive bradycardia. Shen Jin Cao does not contain it, and importing that pharmacology into this monograph would be an error; conversely, a patient who says they are taking club moss may be taking the huperzine drug.

Clinical note: Establish which clubmoss the patient actually has. Ask for the binomial or the Chinese name on the label: Shen Jin Cao or Lycopodii Herba is Lycopodium japonicum, whereas Qian Ceng Ta or a product declaring a huperzine A content in micrograms is Huperzia serrata and must be treated as a cholinesterase inhibitor.

Palhinhaea cernua, Diphasiastrum complanatum and Lycopodiastrum casuarinoides sold as Shen Jin Cao

Theoretical · Unquantified; the substituted species have their own alkaloid profiles · Evidence level: Possible

The Chinese Pharmacopoeia defines Lycopodii Herba as the dried whole plant of Lycopodium japonicum Thunb. alone, but several morphologically similar clubmosses circulate regionally under the same trade name and are distinguished in the Chinese literature mainly by strobilus habit, one having erect and the other pendulous sporangial spikes. Because Lycopodiaceae alkaloid profiles vary substantially between genera, the phytochemistry summarised above cannot be assumed to hold for a substituted article.

Clinical note: Buy from a supplier that states the binomial, and do not assume that material sold as club moss herb is the pharmacopoeial species.

Dosage

FormAmountFrequencyNotes
decoction3–12 gDaily
中国药典 2020 【用法与用量】3~12g。 【性味与归经】微苦、辛,温。归肝、脾、肾经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Evidence

Study design on record, not certainty of outcome.

In vitro / animal
5

Lycojapodine A, a Novel Alkaloid from Lycopodium japonicum

He J, Chen XQ, Li MM, Zhao Y, Xu G, Cheng X, Peng LY, Xie MJ, Zheng YT, Wang YP, Zhao QS · Organic Letters · 2009 · in vitro

In vitro / animal · Not yet verified

Isolation and structure elucidation of lycojapodine A from the whole plant of Lycopodium japonicum, an alkaloid with a 6/6/6/7 tetracyclic ring system carrying a six-membered lactone. In enzyme assay it inhibited acetylcholinesterase with an IC50 of 90.3 micromolar and showed anti-HIV-1 activity with an EC50 of 85 micrograms per millilitre by MTT. Both values are weak and the work is purely preclinical chemistry.

doi:10.1021/ol900079t

Lycojaponicumins A–C, Three Alkaloids with an Unprecedented Skeleton from Lycopodium japonicum

Wang XJ, Zhang GJ, Zhuang PY, Zhang Y, Yu SS, Bao XQ, Zhang D, Yuan YH, Chen NH, Ma SG, Qu J, Li Y · Organic Letters · 2012 · in vitro

In vitro / animal · Not yet verified

Three new alkaloids were isolated from the whole herb, two of them the first natural products reported with a 5/5/5/5/6 pentacyclic skeleton containing a 1-aza-7-oxabicyclo[2.2.1]heptane unit. The compounds inhibited lipopolysaccharide-induced production of pro-inflammatory mediators in BV2 microglial cells. The evidence is cell-culture only.

doi:10.1021/ol3009478

Lycojaponicuminol A–F: Cytotoxic serratene triterpenoids from Lycopodium japonicum

Zhang Y, Yi P, Chen Y, Mei ZN, Hu X, Yang GZ · Fitoterapia · 2014 · in vitro

In vitro / animal · Not yet verified

Six new serratene triterpenoids were isolated from the whole plant. Several of them, together with 3-epilycoclavanol and lycernuic acid A, were moderately cytotoxic against A549, HepG2 and MCF-7 human tumour cell lines with IC50 values of 2.28 to 11.81 micrograms per millilitre. No animal or human data follow from this work.

doi:10.1016/j.fitote.2014.04.012

Lycojapomines A–E: Lycopodium Alkaloids with Anti-Renal Fibrosis Potential from Lycopodium japonicum

Xia D, Wang ZH, Jiang JM, Yang XW, Gao Y, Xu YY, Chang LY, Zhu D, Zhao BJ, Zhu XL, Zhang J, Yin ZQ, Pan K · Organic Letters · 2022 · in vitro

In vitro / animal · Not yet verified

Five new Lycopodium alkaloids were isolated from Lycopodium japonicum and assessed in a cell model of renal fibrosis, where members of the series attenuated fibrotic marker expression. The finding is an isolated preclinical signal and does not support any clinical use of the herb in kidney disease.

doi:10.1021/acs.orglett.2c01877

Natural Tyrosinase Inhibitors from Lycopodium japonicum

Ge ZY, Wang YQ, Yang QB, Yan XY, Wu L, Zhang M, Liang LF · Molecules · 2025 · in vitro

In vitro / animal · Not yet verified

Fifteen secondary metabolites were isolated from Lycopodium japonicum and screened for tyrosinase inhibition; five were active, but with IC50 values of 1.46 to 6.82 millimolar, which is very weak inhibition and of interest mainly as a chemical observation.

doi:10.3390/molecules30194024

Safety

Contraindications

Its use is prohibited in patients with excessive bleeding or pregnant women.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 105–112.

Cultural and historical

Ben Cao Shi Yi (Supplement to Materia Medica), Chen Cangqi · Tang dynasty, circa 739 CE

Earliest recorded entry for the drug, under the name Shi Song (stone pine). The text describes a plant growing on rocks that resembles a pine and stands one or two feet high, indicated for wind impediment, cold in the knees and legs, numbness of the skin and weakened strength. This is the origin of the later name Shen Jin Cao, literally stretch-the-sinews herb.

Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen · Ming dynasty, 1596

Carries the Shi Song entry forward in the herb section, retaining the wind-damp and sinew-relaxing indications recorded in the Tang source.

Pharmacopoeia of the People's Republic of China, Lycopodii Herba (Shen Jin Cao) · Modern, 2020 edition

Defines the official drug as the dried whole plant of Lycopodium japonicum Thunb. alone, and specifies microscopic and thin-layer chromatographic identification. Related clubmosses circulating under the same trade name are not the pharmacopoeial article.

References

  1. Chen Y, Yang Q, Zhang Y. Lycopodium japonicum: A comprehensive review on its phytochemicals and biological activities. Arabian Journal of Chemistry. 2020 doi:10.1016/j.arabjc.2020.03.023
  2. Wang B, Guan C, Fu Q. The traditional uses, secondary metabolites, and pharmacology of Lycopodium species. Phytochemistry Reviews. 2022 doi:10.1007/s11101-021-09746-4
  3. Ferreira A, Rodrigues M, Fortuna A, Falcão A, Alves G. Huperzine A from Huperzia serrata: a review of its sources, chemistry, pharmacology and toxicology. Phytochemistry Reviews. 2016 doi:10.1007/s11101-014-9384-y
  4. He J, Wu XD, Liu F, Liu YC, Peng LY, Zhao Y, Cheng X, Luo HR, Zhao QS. Lycopodine-Type Alkaloids from Lycopodium japonicum. Natural Products and Bioprospecting. 2014 doi:10.1007/s13659-014-0027-1
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice